No CAD, n = 2527 | CAD, n = 62 | P | |
---|---|---|---|
Any adverse events, % (n) | 13.4% (334) | 12.9% (8) | 1.000 |
Device malfunction | 0.3% (8) | 0.0% (0) | .a |
Dissection/perforation | 2.8% (70) | 4.8% (3) | .a |
Clot migration/embolism | 3.1% (78) | 4.8% (3) | .a |
Intracerebral hemorrhage | 2.2% (55) | 0.0% (0) | .a |
Vasospasm | 2.6% (65) | 4.8% (3) | .a |
New persistent neurological deficit | 0.0% (2) | 0.0% (0) | .a |
New transient neurological deficit | 0.0% (1) | 0.0% (0) | .a |